The patient's perspective of the adverse effects of glucocorticoid use: A systematic review of quantitative and qualitative studies. From an OMERACT working groupJonathan T. L. Cheah, Catherine Hill, Joanna Robson et al.|Seminars in Arthritis and Rheumatism|2020Cited by 32
A Patient-reported Outcome Measure for Effect of Glucocorticoid Therapy in Adults with Inflammatory Diseases Is Needed: Report from the OMERACT 2016 Special Interest GroupRachel Black, Catherine Hill, Elizabeth Hoon et al.|The Journal of Rheumatology|2017Cited by 22
Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain setJoanna Tieu, Catherine Hill, Jonathan TL. Cheah et al.|Seminars in Arthritis and Rheumatism|2021Cited by 12
Toward a Core Domain Set for Glucocorticoid Impact in Inflammatory Rheumatic Diseases: The OMERACT 2018 Glucocorticoid Impact Working GroupJonathan T. L. Cheah, Catherine Hill, Rachel Black et al.|The Journal of Rheumatology|2019Cited by 10